|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0305 USD | -7.58% |
|
+7.02% | +17.31% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -7.58% | +7.02% | -26.86% | +30,400.00% | +17.31% | -70.92% | -96.76% | -99.16% | -99.62% | 8.75M | |
| +0.16% | +6.92% | +10.19% | +1.44% | -9.80% | +24.74% | -6.16% | +19.39% | +63.77% | 70.73B | |
| +0.28% | +3.12% | -4.78% | +10.92% | +5.16% | +35.58% | +211.60% | +173.91% | +258.58% | 54.27B | |
| -4.52% | +47.90% | +47.90% | +47.90% | +47.90% | +47.90% | +47.90% | +47.90% | - | 49.28B | |
| +7.15% | +5.51% | +11.49% | -0.64% | -25.82% | -52.67% | -51.99% | -55.77% | +9.00% | 39.94B | |
| +1.12% | +5.56% | -3.65% | +7.38% | +18.60% | +63.20% | -22.75% | -36.59% | -28.01% | 30.36B | |
| -1.51% | +11.13% | +12.22% | +29.84% | +30.28% | +66.30% | +101.94% | +66.25% | +42.64% | 25.96B | |
| -0.66% | -5.51% | -21.28% | +20.01% | +86.06% | +68.00% | -53.37% | -84.13% | - | 22.14B | |
| -0.22% | -2.66% | +19.36% | +8.60% | +17.64% | -4.47% | +145.08% | +19.28% | - | 19.96B | |
| -0.43% | +2.13% | +17.23% | +19.00% | +10.37% | +82.25% | +141.13% | +55.24% | - | 16.77B | |
| +1.37% | +2.16% | +2.29% | +12.67% | +42.19% | +67.45% | +129.71% | +185.92% | +332.94% | 16.72B | |
| -1.93% | -3.89% | -4.48% | +25.20% | +26.10% | +129.37% | +193.50% | +355.43% | +2,845.14% | 12.05B | |
| -0.90% | +5.42% | +6.75% | +13.57% | +3.59% | +5.73% | -29.98% | -21.58% | -38.08% | 12B | |
| -4.72% | +3.48% | -17.76% | -24.97% | -37.15% | -38.18% | +566.27% | +315.44% | +4,570.49% | 10.92B | |
| -0.18% | +7.85% | -3.95% | +39.73% | +47.33% | +138.84% | +181.36% | +506.90% | - | 10.74B | |
| +3.67% | +6.29% | +15.06% | +17.46% | -3.22% | -16.49% | -22.43% | -51.70% | -47.20% | 6.86B | |
| +1.80% | +29.20% | +29.26% | +52.24% | +95.56% | +165.62% | +328.18% | +440.32% | - | 6.1B | |
| +5.47% | +3.32% | +26.67% | +13.08% | +0.06% | +14.84% | +50.95% | -8.69% | - | 5.68B | |
| -2.02% | -6.60% | -0.39% | -19.56% | +0.53% | +9.16% | +192.84% | +219.56% | - | 5.58B | |
| -1.33% | -8.61% | -12.46% | +51.85% | +171.44% | +148.20% | +253.74% | -27.70% | - | 5.51B | |
| Average | -0.28% | +2.27% | +5.14% | +1,536.29% | +27.21% | +44.22% | +113.04% | +101.01% | +719.06% | 21.08B | |
| Weighted average by Cap. | +0.09% | +2.26% | +9.21% | +16.01% | +17.49% | +38.08% | +81.25% | +72.05% | +386.42% |
- Stock Market
- Stocks
- ADAPY Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
